Research Triangle Park, NC — (Marketwired) – May 28, 2015 – Fennec Pharmaceuticals Inc. (TSX: FRX, OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated April 23, 2015 (the “Circular”) for the Annual Meeting of Shareholders were elected as directors of the Company at the Annual Meeting of Shareholders held in Durham, North Carolina on May 28, 2015 (the “Meeting”). Detailed results of the vote for the election of directors are set out below:
Name of Nominee |
|
|
|
|
| Dr. Khalid Islam | 5,811,119 | 99.96% | 2,467 | 0.04% |
| Mr. Adrian Haigh | 5,067,580 | 87.17 % | 746,006 | 12.83% |
| Mr. Chris A. Rallis | 5,067,580 | 87.17 % | 746,006 | 12.83% |
| Mr. Rostislav Raykov | 5,067,242 | 87.16% | 746,344 | 12.84% |
| Mr. Steven D. Skolsky | 5,067,572 | 87.17% | 746,014 | 12.83% |
For further information, please contact:
Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144